Colgate-Palmolive (NYSE:CL) Shares Sold by Zevin Asset Management LLC

Zevin Asset Management LLC decreased its position in Colgate-Palmolive (NYSE:CL) by 2.2% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 131,509 shares of the company’s stock after selling 2,987 shares during the quarter. Colgate-Palmolive comprises about 2.1% of Zevin Asset Management LLC’s holdings, making the stock its 19th largest position. Zevin Asset Management LLC’s holdings in Colgate-Palmolive were worth $13,652,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD grew its holdings in Colgate-Palmolive by 27.8% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company’s stock valued at $3,698,096,000 after buying an additional 8,933,912 shares during the period. Massachusetts Financial Services Co. MA grew its holdings in Colgate-Palmolive by 40.7% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 8,969,498 shares of the company’s stock valued at $870,400,000 after buying an additional 2,593,313 shares during the period. Legal & General Group Plc grew its holdings in Colgate-Palmolive by 0.8% in the 2nd quarter. Legal & General Group Plc now owns 7,785,101 shares of the company’s stock valued at $755,465,000 after buying an additional 61,413 shares during the period. GUARDCAP ASSET MANAGEMENT Ltd grew its holdings in Colgate-Palmolive by 4.1% in the 1st quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 6,987,454 shares of the company’s stock valued at $629,220,000 after buying an additional 278,150 shares during the period. Finally, Acadian Asset Management LLC grew its holdings in Colgate-Palmolive by 108.4% in the 2nd quarter. Acadian Asset Management LLC now owns 5,682,280 shares of the company’s stock valued at $551,367,000 after buying an additional 2,955,442 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the company. Wells Fargo & Company decreased their target price on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a report on Monday, October 28th. StockNews.com upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating in a report on Thursday. Jefferies Financial Group cut Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their price target for the stock from $103.00 to $95.00 in a report on Wednesday, July 24th. TD Cowen decreased their price target on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating for the company in a report on Monday, October 28th. Finally, Redburn Atlantic upgraded Colgate-Palmolive to a “hold” rating in a report on Thursday, August 1st. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $105.11.

Colgate-Palmolive Stock Up 2.3 %

Shares of Colgate-Palmolive stock opened at $93.56 on Monday. The stock has a 50-day moving average price of $99.31 and a 200 day moving average price of $98.54. The company has a market cap of $76.44 billion, a P/E ratio of 26.81, a P/E/G ratio of 3.34 and a beta of 0.42. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 1 year low of $75.17 and a 1 year high of $109.30.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.14%. The ex-dividend date of this dividend was Friday, October 18th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the firm’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the sale, the director now owns 11,755 shares of the company’s stock, valued at $1,220,874.30. This trade represents a 16.44 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.